Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10751138rdf:typepubmed:Citationlld:pubmed
pubmed-article:10751138lifeskim:mentionsumls-concept:C0025011lld:lifeskim
pubmed-article:10751138lifeskim:mentionsumls-concept:C0038522lld:lifeskim
pubmed-article:10751138lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:10751138lifeskim:mentionsumls-concept:C0205145lld:lifeskim
pubmed-article:10751138lifeskim:mentionsumls-concept:C1721019lld:lifeskim
pubmed-article:10751138lifeskim:mentionsumls-concept:C0005456lld:lifeskim
pubmed-article:10751138lifeskim:mentionsumls-concept:C1824669lld:lifeskim
pubmed-article:10751138lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:10751138pubmed:issue4lld:pubmed
pubmed-article:10751138pubmed:dateCreated2000-6-1lld:pubmed
pubmed-article:10751138pubmed:abstractTextMeasles virus (MV) binding sites of the CD46 gene were sequenced in patients with subacute sclerosing panencephalitis (SSPE) and in controls. There were 3 novel polymorphisms, including C/T at nucleotide position 38 (C/T38), G/A at position 176 (G/A176), and C/T at position 453 (C/T453), at allele frequencies of.97:.03, .99:.01, and.97:.03, respectively. The G/A176 polymorphism causes an Arg/Gln amino acid change within the essential binding sites of MV, whereas the C/A38 polymorphism causes a Ser/Phe change outside the MV binding sites. The C/T453 polymorphism does not produce an amino acid change. Two of the 40 SSPE patients and 2 of the 32 controls had both C/T38 and C/T453 polymorphisms in heterozygous patterns. One control subject, but no SSPE patients, had the G/A176 polymorphism in a heterozygous pattern. Thus, it is not likely that CD46 gene alteration has a role as a host susceptibility factor in the development of SSPE.lld:pubmed
pubmed-article:10751138pubmed:languageenglld:pubmed
pubmed-article:10751138pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10751138pubmed:citationSubsetAIMlld:pubmed
pubmed-article:10751138pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10751138pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10751138pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10751138pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10751138pubmed:statusMEDLINElld:pubmed
pubmed-article:10751138pubmed:monthAprlld:pubmed
pubmed-article:10751138pubmed:issn0022-1899lld:pubmed
pubmed-article:10751138pubmed:authorpubmed-author:KoideNNlld:pubmed
pubmed-article:10751138pubmed:authorpubmed-author:YamashitaSSlld:pubmed
pubmed-article:10751138pubmed:authorpubmed-author:HaraTTlld:pubmed
pubmed-article:10751138pubmed:authorpubmed-author:NiheiKKlld:pubmed
pubmed-article:10751138pubmed:authorpubmed-author:SasakiYYlld:pubmed
pubmed-article:10751138pubmed:authorpubmed-author:HattoriHHlld:pubmed
pubmed-article:10751138pubmed:authorpubmed-author:KusuharaKKlld:pubmed
pubmed-article:10751138pubmed:authorpubmed-author:TakeshitaKKlld:pubmed
pubmed-article:10751138pubmed:authorpubmed-author:IharaKKlld:pubmed
pubmed-article:10751138pubmed:authorpubmed-author:AibaHHlld:pubmed
pubmed-article:10751138pubmed:authorpubmed-author:NakaoFFlld:pubmed
pubmed-article:10751138pubmed:issnTypePrintlld:pubmed
pubmed-article:10751138pubmed:volume181lld:pubmed
pubmed-article:10751138pubmed:ownerNLMlld:pubmed
pubmed-article:10751138pubmed:authorsCompleteYlld:pubmed
pubmed-article:10751138pubmed:pagination1447-9lld:pubmed
pubmed-article:10751138pubmed:dateRevised2006-5-11lld:pubmed
pubmed-article:10751138pubmed:meshHeadingpubmed-meshheading:10751138...lld:pubmed
pubmed-article:10751138pubmed:meshHeadingpubmed-meshheading:10751138...lld:pubmed
pubmed-article:10751138pubmed:meshHeadingpubmed-meshheading:10751138...lld:pubmed
pubmed-article:10751138pubmed:meshHeadingpubmed-meshheading:10751138...lld:pubmed
pubmed-article:10751138pubmed:meshHeadingpubmed-meshheading:10751138...lld:pubmed
pubmed-article:10751138pubmed:meshHeadingpubmed-meshheading:10751138...lld:pubmed
pubmed-article:10751138pubmed:meshHeadingpubmed-meshheading:10751138...lld:pubmed
pubmed-article:10751138pubmed:meshHeadingpubmed-meshheading:10751138...lld:pubmed
pubmed-article:10751138pubmed:meshHeadingpubmed-meshheading:10751138...lld:pubmed
pubmed-article:10751138pubmed:meshHeadingpubmed-meshheading:10751138...lld:pubmed
pubmed-article:10751138pubmed:meshHeadingpubmed-meshheading:10751138...lld:pubmed
pubmed-article:10751138pubmed:meshHeadingpubmed-meshheading:10751138...lld:pubmed
pubmed-article:10751138pubmed:meshHeadingpubmed-meshheading:10751138...lld:pubmed
pubmed-article:10751138pubmed:meshHeadingpubmed-meshheading:10751138...lld:pubmed
pubmed-article:10751138pubmed:meshHeadingpubmed-meshheading:10751138...lld:pubmed
pubmed-article:10751138pubmed:meshHeadingpubmed-meshheading:10751138...lld:pubmed
pubmed-article:10751138pubmed:year2000lld:pubmed
pubmed-article:10751138pubmed:articleTitleAnalysis of measles virus binding sites of the CD46 gene in patients with subacute sclerosing panencephalitis.lld:pubmed
pubmed-article:10751138pubmed:affiliationDept. of Pediatrics, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. kkusuhar@pediatr.med.kyushu-u.ac.jplld:pubmed
pubmed-article:10751138pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:4179entrezgene:pubmedpubmed-article:10751138lld:entrezgene